immune checkpoint inhibitors in mds: the i4mds consortium
Published 4 months ago • 120 plays • Length 2:53Download video MP4
Download video MP3
Similar videos
-
4:27
the role of immune checkpoint inhibitors in mds
-
5:42
immune checkpoint inhibitors in mds and aml
-
9:41
the i4mds consortium and immune monitoring in mds
-
7:32
current immune checkpoint inhibitor trials in aml/mds
-
1:59
topics of interest in mds: the role of maintenance therapy, immune checkpoints & ven-aza in hr-mds
-
2:37
immune checkpoint inhibitors for aml: mechanism, rationale & using azacitidine to boost response
-
1:51
checkpoint inhibition in the treatment of mpns
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
12:48
impact of immune checkpoint inhibitors
-
9:25
mgus diagnosis: a step-by-step approach
-
4:55
checkpoint inhibitor combination approaches for aml/mds: an update
-
4:59
checkpoint inhibitors in aml
-
2:00
the incorporation of immunotherapy into frontline all treatment
-
6:50
an overview of the immunotherapy landscape in aml: antibodies, bispecifics, & car-t
-
1:37
the role of the innate immune system in mds & the value of targeting immune signaling pathways
-
1:34
checkpoint inhibitors and their potential role in mm
-
1:18
the mechanism of action of anti-cd47 antibodies & where these may fit in the mds treatment landscape
-
2:28
checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to allosct for hl
-
1:07
identifying operational tolerance pathways after sct & cgvhd immune profiles with machine learning
-
2:03
unmet needs in immune thrombocytopenia
-
2:20
ultra high-risk myeloma